We have developed a flow cytometric method for demonstrating cell fusion between human immunodeficiency virus type 1 (HIV-1)-or HIV-2-infected HUT-78 cells and uninfected CD4-bearing MOLT-4 cells. Syncytium formation due to an interaction between the gpl20 glycoprotein expressed on HIV-infected HUT-78 cells and the CD4 receptor present on MOLT-4 cells, resulted in an immediate decrease in the number of MOLT-4 cells; after a 24 h incubation period almost all MOLT-4 cells had disappeared from the culture. To show that the target MOLT-4 cells and not the aggressor HUT-78 cells were destroyed, specific monoclonal antibodies (MAbs) that reacted with antigens expressed on either MOLT-4 or HUT-78 ceils were used.
INTRODUCTION Human immunodeficiency virus (HIV) is the accepted aetiological agent of AIDS and related disorders (
. The virus is tropic and cytopathic for T cells expressing the CD4 antigen (OKT4A/Leu3a). HIV infects these cells either directly following binding of cell-free virus to the cells (Dalgleish et al., 1984; Klatzmann et al., 1984; McDougal et al., 1986) or indirectly through a cell-to-cell fusion process, by which multinucleated giant cells are formed (Lifson et al., 1986a, b; Sodroski et al., 1986) . The result is a depletion of CD4-positive (CD4 ÷) T cells.
Syncytium formation can be inhibited by several monoclonal antibodies (MAbs) against CD4 (Sattentau et al., 1986) , but not by anti-CD3 or anti-CD8 MAbs nor sera of AIDS patients containing relatively high antibody titres to the envelope glycoproteins (Sodroski et al., 1986) . In addition to anti-CD4 MAb, soluble CD4 and a number of synthetic CD4 peptide fragments are also able to block HIV-induced cell fusion (Lifson et al., 1988) . as well as the high costs of radioisotopes (for reverse transcriptase activity assessments) and of immunological reagents (for antigen capture assays). No rapid and sensitive methods have so far been described for the assay of syncytium formation. The common assay used to examine whether HIV-induced cell fusion occurs and whether it can be counteracted by viral or cellular products or chemical substances is based on counting multinucleated giant cells under the inverted microscope. A first attempt to quantify giant cell formation made use of a cell multisizer (Nakashima et al., 1988) . Using this method the relative cell size could be assessed but the number of giant cells that could be visualized was low and variable.
We have developed a novel fluorocytometric method for evaluating syncytium formation. This new technique allowed us to demonstrate that following, and probably as the consequence of, syncytium formation between persistently HIV-infected T cells and uninfected CD4 target cells, the latter were selectively destroyed. The selective destruction of target CD4 cells by HIVinfected cells may play a crucial role in the pathogenesis of AIDS. The method that we developed to visualize this phenomenon can be readily implemented to evaluate means of blocking HIV-induced cell fusion and the associated target cell destruction.
METHODS

Cells and viruses.
HIV-1 (HTLV-IIIB) and HIV-2 (LAV-2ROl)) were kindly provided by Dr R. C. Gallo (National Cancer Institute, Bethesda, Md., U.S.A.) and Dr L. Montagnier (Pasteur Institute, Paris, France), respectively. The HIV-1-and HIV-2-infected and uninfected (HUT-78, MOLT-4) T cell lines were grown in RPMI 1640 medium supplemented with 10 ~ heat-inactivated foetal calf serum, 100 international units/ml penicillin G and 20 ttg/ml gentamicin. The infected cell lines were established in our laboratory and all T cell lines were mycoplasmanegative.
Compounds. The source of the compounds which were evaluated for their inhibitory effects on giant cell formation was as follows: pentosan polysulphate was purchased from Sigma, Evans Blue and aurintricarboxylic acid from Aldrich; sodium heparin and suramin were kindly provided by Dr W. O. Godtfredson (Leo Pharmaceutical Products) and Dr G. Streissle (Bayer), respectively. All five compounds have been previously shown to inhibit HIV-1 replication selectively in cell culture (Baba et al., 1988a, b, c; Balzarini et al., 1986) .
Monoclonal antibodies. MAbs specific for surface antigens OKT3, OKT4, OKT4A, OKT8 (Ortho Diagnostic Systems), Leul, Leu2a, Leu3a, LeuS, Leul2, Leul5, Leul7, LeulS, LeuM3, HLA-DR, HLA-DQ, IL2R, transferrin receptor (TR) (Becton-Dickinson) and gpl20 (MAS 353, International Medical) were used and examined for inhibition of syncytium formation. The MAbs that were used to determine the phenotypes of the different T cell lines had been labelled with either fluorescein isothiocyanate (FITC) or phycoerythrin (PE). They were purchased from Ortho Diagnostic Systems and Becton-Dickinson. The MAbs used in the syncytium formation assay were unlabelled. Polyclonal antibodies against HIV-I or HIV-2 were sera from patients with AIDS-related complex and showed high specificity by Western blot analysis (DuPon0 for HIV-1 and HIV-2.
Flow cytometry. Cells were incubated for 20 min at 4 °C in RPMI supplemented with the appropriate concentration of MAbs (FITC-or PE-conjugated) and fixed in 0.5~ paraformaldehyde in phosphate-buffered saline.
Flow cytometric analysis was performed using a Becton-Dickinson fluorescence-activated cell sorter (FACSTAR) equipped with an argon-ion laser (Spectrophysies) at 488 nm and 250 mW light output. Before running of the samples the instrument was always calibrated by using fluorescent beads (Flow Cytometry Standard Corporation). Debris and dead cells were excluded from the analysis by the conventional scatter gating method. FITC and PE emission signals were collected by using appropriate filters at 525 and 575 nm, respectively, and amplified logarithmically. Ten thousand events per sample were collected in list mode fashion, stored, and analysed by a Consort 30 system (Becton-Dickinson). The threshold of positivity for green and red fluorescence intensity in two-colour immunofluorescence was arbitrarily established on the basis of the negative control sample of cells incubated with the Simultest Control (IgG1-FITC and IgG2-PE) (Becton-Dickinson).
Two-colour analysis data were depicted by the graphic (contour) representation of three-dimensional surfaces in which the red fluorescence (quadrant 1) and the green fluorescence (quadrant 4) intensities of individual cells defined the location of cells on a 10" x 10" grid and the frequency of cells at each location defined the evaluation of that location; quadrant 2, double positive cells; quadrant 3, double negative cells. Syncytiumformation assay. The unlabelled MAbs, compounds, or antisera from AIDS patients were diluted in RPMI and transferred to fiat-bottomed 96-well microtitre plates (Falcon, Becton-Dickinson). Then 5 x 104 HIV-1-, HIV-2-or non-infected HUT-78 cells, first washed twice to remove free virus particles, were added to the wells, immediately followed by the addition of 5 x 104 MOLT-4 cells, to yield a final volume of 200 ~tl. The mixed cells were cultured at 37 °C in a CO2 cell incubator. The first syncytia arose after 4 to 6 h cultivation. After 20 to 24 h, syncytium formation could be most efficiently quantified, because at this time the maximum number of giant cells was formed in the mixed cell cultures, and no giant ceils were observed in MOLT-4 cells infected with the supernatant of HIV-1-or HIV-2-infected HUT-78 cells. Table 1 a very high percentage (93 to 100K) of the MOLT-4 cells express OKT4, OKT4A (Leu3a), OKT8 (Leu2a), Leul7, Leul8 and TR antigen. In contrast, HUT-78 cells express HLA-DR, HLA-DQ, TR antigen and, to a lesser extent, Leul7 and OKT3 antigen. OKT4 and OKT4A (Leu3a) antigens are expressed by HUT-78 cells only at a very low level. Expression of the surface antigens is similar for uninfected HUT-78 cells and HIV-1-or HIV-2-infected HUT-78 cells, except for the expression of the OKT4A (Leu3a) antigen which decreases to background levels in the infected HUT-78 cells. Both MOLT-4 and HUT-78 cells are negative for Leul, Leu8, Leul2, LeuM3 and the interleukin-2 receptor (IL2R). The MAbs chosen for separating MOLT-4 and HUT-78 cells in the mixed cultures were anti-Leu2a (OKT8), anti-Leu3a (OKT4A) and anti-Leul8 as markers for MOLT-4 and anti-HLA-DR and anti-HLA-DQ as markers for HUT-78. Anti-Leu2a/anti-HLA-DR was chosen as the ideal marker combination. Anti-Leu2a was preferred over anti-Leu3a and anti-Leul8 because the Leu3a (OKT4A) antigen is also involved in HIV binding (Dalgleish et al., 1984) and Leul8 may be expressed, albeit to a minor extent, in HUT-78 cells (Table 1) .
RESULTS
As shown in
When HIV-l-infected HUT-78 cells were cultured with MOLT-4 cells a time-dependent disappearance of the MOLT-4 cells was observed. As early as after 6 h incubation, at the time the first giant cells appeared, the number of MOLT-4 cells began to decrease and at 24 h, they had almost totally disappeared from the culture (Table 2 ). When giant cell formation started, a slight increase in the number of double-stained cells was noted. When gating these cells out, they * After 0, 6, 18 and 24 h cocultivation, the cell clusters were broken by gentle pipetting, and the number of giant ceils was determined microscopically. Data represent mean values and standard deviations for three experiments.
dependent loss of MOLT-4 cells in coculture with HIV-l-infected HUT-78 cells as determined with anti-Leu2a-FITC (MOLT-4 cells) and anti-HLA-DR-PE (HUT-78 cells)
were found back in the upper right corner of the forward scattering/side scattering diagram, which means that they possess the characteristics of very large (giant) granular cells (data not shown).
As seen in Fig. 1 (first row), MOLT-4 (approx. 60%) and HUT-78 cells (approx. 30%) can be totally separated from each other by using OKT4A-FITC, Leul8-FITC, Leu2a-FITC and (Nakashima et al., 1987) , treatment of the cocultures for 24 h with 3'-azido-2',3'-dideoxythymidine (5 ~t~) did not inhibit syncytium formation; nor did it protect MOLT-4 cells from destruction (data not shown).
In Fig. 2 and 3 we show contour plot diagrams for coculture of HIV-l-infected HUT-78 cells (Fig. 2) or HIV-2-infected HUT-78 cells (Fig. 3) with MOLT-4 cells, which had been incubated for 24 h and then stained with anti-Leu2a-FITC and anti-HLA-DR-PE MAbs. The HLA-DRpositive HIV-1-and HIV-2-infected HUT-78 cells alone are situated in the first quadrant ( Fig.  2a and 3a) . The Leu2a-positive MOLT-4 cells are situated in the fourth quadrant (Figs. 2b and  3b) . The cells mixtures of uninfected HUT-78 and MOLT-4 cells are, as could be expected, positioned in both quadrants 1 and 4 ( Fig. 2c and 3c) 
Fig. 3. After culturing of HIV-2-infected HUT-78 cells alone (a), MOLT-4 cells alone (b), HUT-78 cells together with MOLT-4 cells (c) and HIV-2-infected HUT-78 cells together with MOLT-4 cells (d, e,f, g, h, i, j, k and/) for 24 h, the cells were stained with anti-Leu2a-FITC and anti-HLA-DR-PE for determining the percentage of MOLT-4 cells and HUT-78 cells, respectively. MOLT-4 cells were mixed
with HUT-78 cells at a 1 : 1 ratio (5 x l0 s ceUs/ml, each). Also present during the 24 h incubation period were the following (unlabelled) MAbs: OKT4A at 1 gg/ml (e) and 0.2 lag/ml (f), OKT4 at 1 ~tg/ml (g) and 0.2 gg/ml (h), OKT3 at 1 ixg/ml (0 and 0-2 ~tg/ml (j), and Leu3a at 1 p.g/ml (k) and 0-2 ixg/ml (/). A clear protective effect is demonstrated with OKT4A MAb (e and f) and Leu3a MAb (k and/), whereas OKT3 MAb (i and j), is totally inactive. OKT4 (g) shows some protection. Also note a shift towards double-stained cells with OKT-4 (g). The amount of double-stained cells in the HIV-2-infected HUT-78/MOLT-4 cells cocultures is about 129/oo. quadrant 1 (Fig. 2d and 3d) . The HIV-1-and HIV-2-infected HUT-78/MOLT-4 cocultures were also incubated in the presence of MAbs with the following specificities: OKT4A, 1 ~tg/ml ( Fig.  2e and 3e) ; OKT4A, 0.2 ~tg/ml ( Fig. 2fand 3f) ; OKT4, 1 ~tg/ml ( Fig. 2g and 3g) ; OKT4, 0.2 Ixg/ml ( Fig. 2h and 3h) ; OKT3, 1 ~tg/ml (Fig. 2i and 3/) ; OKT3, 0.2 ~tg/ml ( Fig. 2j and 3j) ; Leu3a, 1 ~tg/ml ( Fig. 2k and 3k) and Leu3a, 0.2 ~tg/ml (Fig. 2/and 30 . OKT4A and Leu3a MAbs completely protected the MOLT-4 cells against cell fusion and destruction at a concentration of 1 I~g/ml ( Fig. 2e and 2k ). These MAbs were fully protective against the destructive effect of HIV-2-infected HUT-78 cells at a concentration as low as 0-2 ~tg/ml (Fig. 3fand 31) . Also, the OKT4 MAb showed some protective effects against HIV-1 (Fig. 2g) , and to a greater extent against HIV-2 (Fig. 3g) . OKT3 MAb showed no protection at all (Fig. 2i and 3/) . The percentages of fluorescence-positive cells, as visualized by using anti-Leu2a-FITC and anti-HLA-DR-PE, are presented in Tables 3 and 4 . From Table 3 it is clear that OKT4A MAb and Leu3a MAb at a concentration between 0.04 and 5 ~tg/ml protected MOLT-4 cells against the destructive effect of both HIV-1-and HIV-2-infected HUT-78 cells. In fact, both MAbs were more protective against HIV-2-than HIV-l-infected cells. OKT4 MAb offered protection only at a concentration of 1 to 5 Ixg/ml, whereas OKT3 MAb was essentially inactive.
As shown in Table 4 anti-gpl20 MAb at 50 Ixg/ml showed some protection against HIV-1-infected cells but not against HIV-2-infected cells, suggesting that the glycoprotein gpl20 ¶ IC5o = 50% fusion inhibitory concentration = exp (loglo c -([(a -50)/(a -b)] x loglo d}) where a is more than 50 % inhibition; b is less than 50 % inhibition; d is the dilution factor (= 5) and c is the concentration of MAb (~tg/ml) leading to less than 50% inhibition. expressed on the HIV-l-infected HUT-78 cells is quite different from that on the HIV-2-infected cells. Specific HIV-1 and HIV-2 antisera obtained from AIDS patients, containing antibodies to the envelope glycoproteins [gp 160, gp120, gp41, as demonstrated by Western blot analysis (data not shown)l, did not protect the MOLT-4 ceils against the destructive effects of either HIV-1-or HIV-2-infected HUT-78 cells (Table 4) . Anti-Leul8, anti-LeuM3, anti-Leu2a and anti-HLA-DR MAbs had no protective effect on MOLT-4 cells (data not shown).
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The different parameters by which cell fusion could be indicated are presented in Tables 5 and  6 (cocultures of MOLT-4 cells and HIV-1-or HIV-2-infected HUT-78 cells, respectively). To calculate the fusion indexes (FIs), the percentages of MOLT-4 and HUT-78 have to be corrected because the total percentage of MOLT-4 and HUT-78 cells stained for the presence of Leu2a + and HLA-DR +, respectively, is slightly less than 100%. The FI is calculated as explained in the footnote to Table 5 , and varies from 0 (no fusion) to 1 (total fusion); fusion inhibition is expressed as a percentage and the concentration of the compound required to inhibit fusion by 50% is identified as the IC50. In the absence of any inhibitor, the FI should reach a value that is close to 1, which was the case for both the HIV-l-infected HUT-78/MOLT-4 and the HIV-2-infected HUT-78/MOLT-4 cell systems (Tables 5 and 6 ).
The IC50 values were determined for MAbs against OKT4A, OKT4, OKT3 and Leu3a. The IC5o of the OKT3 MAb was considerably higher than 5 ~tg/ml. The OKT4 MAb had an ICs0 of > 5 ~tg/ml for HIV-l-infected cells and an IC5o of 3.7 ~tg/ml for HIV-2-infected cells. For the OKT4A MAb, the corresponding IC50 values were 0-46 and 0-05 ktg/ml, respectively. The lowest IC50 values were recorded for the anti-Leu3a MAb, which inhibited fusion induced by HIV-2-infected cells at a concentration of < 0.04 ~tg/ml ( Table 5. polysulphate, suramin, heparin, Evans Blue (Schols et al., 1989a)] or to interact with the CD4 receptor [aurintricarboxylic acid (Schols et al., 1989b) ] were chosen as candidates for further evaluation in the syncytium formation assay. As shown in Table 7 , pentosan polysulphate, suramin, aurintricarboxylic acid and Evans Blue protected MOLT-4 cells against the destructive effect of HIV-l-infected HUT-78 cells on MOLT-4 cells. The lowest ICs0 values were recorded for Evans Blue and aurintricarboxylic acid. They inhibited killing of MOLT-4 cells by HIV-1-infected HUT-78 cells at an ICs0 of 1.7 and 6-9 p.g/ml, respectively. Suramin had an IC50 of 45.9 Ixg/ml. Heparin was totally inactive at a concentration of 100 Ixg/ml, whereas pentosan polysulphate had an IC5o of 26.6 ktg/ml (Table 7) . 
DISCUSSION
The binding of the viral gpl20 to the CD4 receptor is the initial step in both HIV-induced syncytium formation (Lifson et al., 1986a, b; Sodroski et al., 1986) and cell-free virus infection (McDougal et aL, 1986) . The 50~ inhibitory concentration for blocking HIV-induced cell fusion in cocultures of HIV-l-infected CEM cells and CBL1 cells is 0-12 ~g/ml for the OKT4A/Leu3a MAb and > 20 ~tg/ml for the OKT4 MAb, as assessed by counting giant cells (Sattentau et al., 1986) . Comparable ICs0 values were obtained (0.13 gg/ml for the anti-Leu3a MAb, 0.46 gg/ml for the OKT4A MAb and > 5 gg/ml for the OKT4 MAb; Table 5 in our HIV-l-infected HUT-78/MOLT-4 assay system. It is notable that these MAbs are more active in the HIV-2-infected HUT-78/MOLT-4 assay, although the HIV-1-and HIV-2-infected HUT-78/MOLT-4 systems have a very similar FI (0.952 and 0.962, respectively).
Since HIV-induced syncytium formation is blocked at lower MAb concentrations than cellfree virus infection, it has been postulated by Dalgleish et al. (1984) that for syncytium formation more CD4-gpl20 interactions are required than for cell-free virus infection. The different effects of the OKT4A/Leu3a MAb on HIV-1-and HIV-2-infected cell syncytium formation also points to a lower density of gpl20 molecules on the surface of HIV-2-infected than on HIV-1-infected cells. Alternatively, the gpl20 of HIV-1 may have a higher affinity for CD4 molecules or other HIV components, i.e. gp41 may help gpl20 in achieving its interaction with the CD4 receptor and, hence, help gpl20 in inducing syneytium formation (Kowalski et al., 1987) .
To block syncytium formation, very high amounts of anti-gpl20 MAb (>50 gg/ml) are needed (Table 4 ) (see also Skinner et al., 1988) and with specific anti-HIV-1 or anti-HIV-2 sera, no inhibitory effect on syncytium formation could be achieved (Table 4) . Sodroski et al. (1986) have also observed that most patients' sera fail to inhibit syncytium formation. Hence, cell-tocell transmission of the virus would not be prevented in most patients, and this failure must undoubtedly lead to a progression of the disease.
With the aid of double fluorescence labelling (rhodamine isothiocyanate for one cell line and FITC for the second cell line), Lifson et al. (1986a, b) have shown that multinucleated giant ceils are actually formed through cell fusion. The resulting giant cells exhibited both red and green fluorescence, which is indicative of cell fusion. However, the ratio of giant cells to the total cell population is very low and, moreover, giant cells are very fragile and die very soon after they are formed, thus posing a serious problem for quantitative enumeration. The rapid destruction of the CD4 target cells following their fusion with the aggressor cells has now been used as the basis for the development of a rapid and sensitive assay that can determine within 24 h whether a given substance is capable of blocking syncytium formation between HIV-infected and uninfected cells. The assay requires the use of adequate surface markers to differentiate between the target (uninfected) cells and aggressor (HIV-infected) cells. The gradual destruction of the target cells can be easily monitored by counting the residual cells, and functions as a parameter for syncytium formation. In the present study, MOLT-4 cells served as the target cells and persistently HIV-infected HUT-78 cells as the aggressor cells. MAbs to cell surface antigens of the target cells were found to protect the cells against the aggressor cells at concentrations that were quite comparable to those found inhibitory to giant cell formation by other investigators (Sattentau et al., 1986) .
We have found that pentosan polysulphate, suramin, aurintricarboxylic acid and Evans Blue, in addition to their inhibitory effects on virus replication (Baba et al., 1988 a, b, c; Balzarini et al., 1986) and virus adsorption to the cell membrane (Mitsuya et al., 1988; Baba et al., 1988a, b; Schols et al., 1988) , are also capable of inhibiting giant cell formation. The IC5o values obtained with this flow cytometric method for monitoring giant cell formation corresponded closely to the ICs0 values recorded on the basis of microscopic enumeration of giant cells (M. Baba et al., unpublished data) .
Using this method we have demonstrated that following syncytium formation between persistently HIV-infected cells and target bystander cells, the latter are rapidly destroyed. Thus, giant cell formation between infected and uninfected cells leads to the selective elimination of the uninfected cells. If applicable to the in vivo situation, this selective killing of bystander target cells by the chronically HIV-infected aggressor cells could play an important role in the HIV, syncytium formation and CD4 + cell destruction 2407 pathogenesis of AIDS and related diseases, as suggested by others (Haseltine, 1988) . Not only does the 'cell fusion-destruction' phenomenon that we have observed elucidate the role such fusion and destruction may play in the pathogenesis of the disease, it also provides the basis for a sensitive and reliable method for the detection of compounds that may suppress this process and hence arrest progression of the disease.
